Figure 2.
OS by therapy received, stratified by TP53mutVAF. OS for patients receiving a cytarabine-based regimen (A) or an HMA-based regimen (B), stratified by TP53mut VAF.

OS by therapy received, stratified by TP53mutVAF. OS for patients receiving a cytarabine-based regimen (A) or an HMA-based regimen (B), stratified by TP53mut VAF.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal